Diabetes

This article reviews real-world data presented at the ADA Scientific Sessions 2024. It demonstrates the glycaemic range when Control-IQ Technology users do not manually bolus for extended periods

A 21-year-old female with a history of Type 1 diabetes mellitus (T1DM) with baseline HbA1c ranging from 8.8–12.5%, delayed menarche…

Obesity is a major risk factor for the development of Type 2 diabetes (T2D), with the prevalence of both increasing in a parallel manner…

HCL systems have the potential to improve glycaemic control in people living with T1D.1-4 HCLs combine continuous glucose monitoring…

Since the release of the EMPA-REG trial, in which for the first time an antihyperglycaemic agent demonstrated a reduction…

Diabetes is emerging as an epidemic worldwide and is a global public health problem. The International Diabetes Federation (IDF)…

According to the World Health Organization (WHO), the number of people with diabetes has quadrupled since the 1980s, with estimates…

Type 2 diabetes (T2D) is a persistent metabolic anarchy, described by hyperglycaemia resulting from defects in insulin secretion…